INHIBITION OF LYMPHOCYTE-IL2-RECEPTOR EXPRESSION BY FACTOR-VIII CONCENTRATE - A POSSIBLE CAUSE OF IMMUNOSUPPRESSION IN HEMOPHILIACS

被引:29
作者
HAY, CRM
MCEVOY, P
DUGGANKEEN, M
机构
[1] Department of Haematology, University of Liverpool, Royal Liverpool Hospital, Liverpool, The Duncan Building
关键词
D O I
10.1111/j.1365-2141.1990.tb02663.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Factor VIII concentrate inhibits T‐cell function in vitro and in vivo. The mechanisms underlying this phenomenon were investigated. Factor VIII concentrate has a direct effect on lymphocytes, uninfluenced by haemophilic mono‐cyte dysfunction, since it inhibited lymphocyte transformation with phorbol myriscate acetate, a reaction unaffected by monocyte depletion. Inhibition of lymphocyte transformation by factor VIII concentrate is not corrected by the addition of exogenous IL2, suggesting that it does not inhibit lymphocyte function by suppression of IL2 secretion alone. Factor VIII concentrate causes profound inhibition of IL2‐receptor expression (CD25); with an 89% reduction in CD25‐positive CD4 cells and a 50% reduction in CD25‐antigen molecules per cell. CDS lymphocytes are similarly affected. Smaller reductions in CD71 and HLA‐DR expression are also observed. Down modulation of CD25‐antigen may explain the reduced IL2 secretion observed by others, and may be an important cause of immunodeficiency in HIV‐seronegative haemophiliacs. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:278 / 281
页数:4
相关论文
共 16 条
[1]  
BEDALL AC, 1985, J CLIN PATHOL, V38, P1163
[2]  
BRETTLER DB, 1989, BLOOD, V73, P2067
[3]  
CARR R, 1984, LANCET, V1, P1431
[4]  
CASH JD, 1988, LANCET, V1, P1270
[5]  
DEVRIES JE, 1979, J IMMUNOL, V122, P1099
[6]  
EIBL MM, 1987, BLOOD, V69, P1153
[7]  
FUNDERUD S, 1987, LYMPHOCYTES PRACTICA, P55
[8]  
HAY CRM, 1990, IN PRESS EFFECT DIVE
[9]  
LEDERMAN MM, 1986, J LAB CLIN MED, V107, P471
[10]  
LUDLAM CA, 1985, LANCET, V2, P233